Evidence map›Paper›PMID 24840762›Full record

ArticleThe Journal of pediatrics2014

Vasopressin improves hemodynamic status in infants with congenital diaphragmatic hernia.

Shannon N Acker, John P Kinsella, Steven H Abman, Jason Gien

Open access · greenAbstract read
In one paragraph

Article in The Journal of pediatrics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Vasopressin as adjunctive therapy in pulmonary hypertension associated with refractory systemic hypotension in term newborns.Journal of perinatology : official journal of the California Perinatal Association · 2024
    Observational
  6. Evaluation of Hyponatremia in Infants on Vasopressin Therapy.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Under Pressure: The Pulmonary Vasculature and Its Role in the Pediatric Cardiac ICU.American journal of respiratory and critical care medicine · 2021
    Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shannon N AckerDepartment of Pediatric Surgery, University of Colorado School of Medicine, Aurora, CO. Electronic address: shannon.acker@ucdenver.edu.
John P KinsellaDepartment of Neonatology, University of Colorado School of Medicine, Aurora, CO.
Steven H AbmanDepartment of Pediatric Pulmonary Medicine, University of Colorado School of Medicine, Aurora, CO.
Jason GienDepartment of Neonatology, University of Colorado School of Medicine, Aurora, CO.
University of Colorado Denver · US

Funding

Rho-kinase signaling in lung development and persistent pulmonary hypertensionK08HL102261 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI GIEN, JASON · 2010 to 2014
$662k
NHLBI NIH HHS 5K08HL102261NHLBI NIH HHS K08 HL102261
6 · The paper itself

Abstract

objectiveTo assess the ability of vasopressin to stabilize hemodynamics in infants with systemic hypotension secondary to congenital diaphragmatic hernia (CDH). STUDY

designA retrospective chart review was performed to identify 13 patients with CDH treated with vasopressin for refractory hypotension to assess the effect of vasopressin on pulmonary and systemic hemodynamics and gas exchange in this setting. Data collected included demographics, respiratory support, inotropic agents, pulmonary and systemic hemodynamics, urine output, and serum and urine sodium levels during vasopressin therapy.

resultsVasopressin therapy increased mean arterial pressure and decreased pulmonary/systemic pressure ratio, heart rate, and fraction of inspired oxygen. In 6 of 13 patients, extracorporeal membrane oxygenation therapy was no longer indicated after treatment with vasopressin. Improvement in left ventricular function and oxygenation index after vasopressin initiation was associated with a decreased need for extracorporeal membrane oxygenation therapy. Prolonged vasopressin treatment was associated with hyponatremia, increased urine output, and increased urine sodium.

conclusionsVasopressin stabilized systemic hemodynamics without adverse effects on pulmonary hemodynamics in a subset of infants with CDH. Our results suggest a potential role for vasopressin therapy in patients with CDH with catecholamine-resistant refractory hypotension.

Indexed as

Hernias, Diaphragmatic, CongenitalBlood PressureFemaleHemodynamicsHernia, DiaphragmaticHumansHypotensionInfantMaleRetrospective StudiesTreatment OutcomeVasoconstrictor AgentsVasopressinsVasoconstrictor AgentsVasopressins

Identifiers

PMID24840762
PMCPMC4116488
OpenAlexW2052763052

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.